Michael Langer

Zus is the only shared health data platform designed to accelerate healthcare data interoperability by providing easy-to-use patient data at the point of care via API, embedded components, and direct EHR integrations. Our mission is to catalyze healthcares greatest inventors by maximizing the value of patient insights – so that they can deliver value-based care.

Technology + Biology = Impact

Zus is the only shared health data platform designed to accelerate healthcare data interoperability by providing easy-to-use patient data at the point of care via API, embedded components, and direct EHR integrations. Our mission is to catalyze healthcares greatest inventors by maximizing the value of patient insights – so that they can deliver value-based care.

Pear Therapeutics, Inc., which is traded on Nasdaq as PEAR, is the parent company of Pear Therapeutics (US), Inc. Pear is the leader in developing and commercializing software-based medicines, called prescription digital therapeutics (PDTs). Pear aims to redefine care through the widespread use of clinically validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. Pear has the first end-to-end platform to discover, develop, and deliver PDTs to patients and a pipeline of products and product candidates across therapeutic areas, including the first three PDTs with disease treatment claims from the FDA. Pear’s product, reSET®, for the treatment of substance use disorder, was the first PDT to receive marketing authorization from the FDA to treat disease. Pear’s second product, reSET-O®, for the treatment of opioid use disorder, was the first PDT to receive Breakthrough Designation. Pear’s third product, Somryst® for the treatment of chronic insomnia, was the first PDT submitted through FDA’s traditional 510(k) pathway while simultaneously reviewed through FDA’s Software Precertification Pilot Program. For more information, visit Pear at www.peartherapeutics.com.

One of the worlds largest science centers and New England’s most attended cultural institution, the Museum of Science, Boston introduces 1.5 million visitors a year to science, technology, engineering, and math (STEM) via dynamic programs and hundreds of interactive exhibits. The Museum of Science carries out its mission as a leader in transforming the nation’s relationship with science and technology through world-class exhibits, industry-leading curriculum, and innovative programming. As science and technology shapes our lives, it means we: • Promote active citizenship • Inspire lifelong appreciation of the importance of science • Make STEM accessible to young people of all backgrounds and abilities These principles manifest every day in all we do within the Museum walls as well as around the world, as a steward of our community, as informal and formal educators, and as advocates for scientific advancement. Since its founding in 1830, the Museum of Science has been at the cutting edge of scientific study and education. Today it has become an iconic symbol of the city’s long cultural and technological history – and future. Within its ¾ mile long building, the Museum of Science includes: • 10,000 square foot Hall of Human Life, allowing visitors to explore how they engage with their own bodies • Thomson Theater of Electricity, home to the world’s largest Van de Graaf generator which makes indoor lightning • Charles Hayden Planetarium, the most technologically advanced theater in New England • Mugar Omni Theater, New England’s only dome IMAX screen • Award-winning pre-K – 8 engineering curriculum, EiE, reaching 1.3 million students each year As a leader in the world’s museum community, we use our role as educator and communicator to bring diverse communities together to learn, share, and consider our collective role in the future of our planet.

Old Silver VC, LLC is a boutique family associated investment firm that makes direct investments in startups and venture capital funds. We mainly focus on healthcare companies but at times will make exceptions for intriguing and innovative proposals. This fund also serves as a consulting/ advisory firm for early stage companies as well. For more look here: http://www.oldsilvervc.com